The FDA has approved the first pill version of Wegovy, expanding access to one of the most popular and effective weight-loss ...

Viking Therapeutics VKTX is one of the few companies with a late-stage obesity candidate in its pipeline. The company is ...

There's a new pill and new ways to pay for the weight-loss drugs known as GLP-1s.

In 2025, the FDA approved 73 first-time generic drugs.  Here are the generics and their indication, in order of approval date: Note: The FDA’s information is current as of Dec. 18. 1. Phytonadione ...

Last month, Novo Nordisk won Food and Drug Administration approval for the first GLP-1 pill for weight loss. The medication, ...

A recently approved injectable eczema drug provides quick itch relief to patients with the maddening skin disease, a new ...

The US drug regulator approved a daily pill version of Novo Nordisk’s Wegovy injection, giving the Danish drugmaker a head ...

Both Novo Nordisk’s and competitor Eli Lilly’s injectable GLP-1 drugs, Wegovy and Zepbound, have helped transform obesity ...

A study suggests twice-yearly Yeztugo offers HIV prevention without adversely affecting gender-affirming care.

Drugs currently shortage FDA total 75 as of Dec. 30, down from 194 in June, mainly hospital injectables and acute care meds.

TempraMed Technologies Ltd. ( ($TSE:VIVI) ) has shared an update. TempraMed Technologies has expanded its distribution partnership with South ...